ULTRAM ER (tramadol hydrochloride) by Bausch + Lomb is mechanism of action ultram er is a centrally acting synthetic opioid analgesic. First approved in 2005.
Drug data last refreshed 1h ago · AI intelligence enriched 6d ago
ULTRAM ER is an extended-release oral tablet containing tramadol hydrochloride, a centrally acting synthetic opioid analgesic approved in 2005. It works through dual mechanisms: binding to µ-opioid receptors (via parent compound and the more potent M1 metabolite) and weak inhibition of norepinephrine and serotonin reuptake. The product is indicated for moderate to moderately severe pain management in patients requiring around-the-clock analgesia.
As a mature product approaching loss of exclusivity with moderate competitive pressure (30% intensity), commercial teams should anticipate workforce restructuring and transition to generic defense strategies.
Mechanism of Action ULTRAM ER is a centrally acting synthetic opioid analgesic. Although its mode of action is not completely understood, from animal tests, at least two complementary mechanisms appear applicable: binding of parent and M1 metabolite to µ-opioid receptors and weak inhibition of…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on ULTRAM ER at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back Pain
Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets
Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar
Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers
Working on ULTRAM ER offers limited upside career growth given LOE approaching status and zero linked job opportunities at data collection. Professionals on this team should plan strategic transitions to growth-stage products or prepare for potential role reductions as generic erosion accelerates.